Full-Time
Updated on 8/12/2026
Provides eProcurement automation and hosted catalogs
CA$20.37 - CA$35.65/hr
Charlottetown, PE, Canada
In Person
Bachelor's
See people who can refer or advise you
Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.
Company Size
10,001+
Company Stage
IPO
Headquarters
Santa Clara, California
Founded
1999
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Performance Bonus
Stock Options
HALO X-ray Technologies, a UK-based X-ray detection technology company, has completed a funding round led by Agilent Technologies, with participation from existing investors UKI2S and MEIF. The company has developed advanced X-ray diffraction technology designed to help security operators make faster screening decisions at airports and borders. Unlike conventional X-ray systems, HALO's technology provides more precise material identification, helping distinguish genuine threats from everyday items. The investment will support HALO's move towards commercialisation and global market expansion. Geoff Winkett, vice president at Agilent Spectroscopy & Vacuum Division, said the investment reflects confidence in the transformative potential of HALO's technology. CEO Simon Godber described the funding as "genuinely transformational", providing the runway needed to realise the potential of the company's technology and scale commercially.
Agilent Technologies has expanded its Altura HPLC column portfolio with new size exclusion chromatography and PLRP-S columns for biopharmaceutical analysis. The columns support analytical workflows for peptides, proteins, oligonucleotides, and conjugated therapeutics. The new products incorporate Agilent's Ultra Inert technology to improve peak shape and aggregate recovery. For GLP-1 peptide analysis, Altura SEC columns deliver up to double the sensitivity of competitor inert columns. The PLRP-S columns are designed for liquid chromatography/mass spectrometry workflows under demanding conditions. David Edwards, vice president at Agilent's Chemistries and Supplies Division, said customer reception of initial Altura columns has been overwhelmingly positive. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.
Agilent Technologies has closed a $600 million offering of 4.900% senior notes due 2032, the company announced on 25 June 2026. The notes were sold privately to qualified institutional buyers under Rule 144A and non-US persons under Regulation S. The notes carry a fixed 4.900% annual coupon with principal due on 15 January 2032. Interest payments will be made semi-annually starting 15 January 2027. Agilent entered into a registration rights agreement requiring it to file an exchange offer registration statement. If registration obligations are not met by 25 June 2027, the interest rate will increase by 0.25% for the first 90 days of default, up to a maximum additional 0.50% annually. The notes include a change of control provision allowing holders to require repurchase at 101% of principal plus accrued interest.
Agilent Technologies has raised its full-year revenue and earnings per share guidance after reporting stronger-than-expected first and second quarter results. The laboratory equipment maker is also acquiring Biocare to expand its cancer diagnostics capabilities and plans to open a China Innovation Centre focused on digital technology, artificial intelligence and automation. The company is leveraging its IGNITE operating system to drive efficiency gains and margin improvements whilst expanding recurring revenue from consumables and services. Analysts project the moves could support Agilent's push into AI-driven automation and diagnostics, though tariff-related costs and supply chain complexity remain key risks. Simply Wall St community members currently value Agilent's shares between $150.54 and $165.53, suggesting potential upside from current levels based on the company's margin expansion efforts.
Madison Large Cap Fund maintained its position in Agilent Technologies during the first quarter of 2026, despite the stock being among the fund's top five detractors. The fund declined 2.7%, outperforming the S&P 500's 4.33% fall. Agilent, a life sciences and diagnostics solutions provider, reported results consistent with expectations, though its 2026 recovery outlook disappointed investors. The stock also faced concerns about AI technology potentially reducing demand for laboratory instruments by enabling simulated research experiments. Madison dismissed these AI risks as unlikely, noting early-stage R&D represents only a small portion of Agilent's revenue. The company reported $1.83 billion in second-quarter revenue, up 6.3% on a core basis. As of 15 June 2026, Agilent traded at $130.59 per share with a market capitalisation of $36.88 billion.